Disclaimer: You are now leaving www.beiresources.org and are going to a website that is not operated by BEI Resources. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE: BEI Resources offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the BEI Resources website and will be redirected to another site. These sites are not under the control of BEI Resources. BEI Resources is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Please read third party privacy and security policies closely as these may be different than BEI Resources policies. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
At BEI Resources, we're the leading source for high quality cultures and reagents for microbiology and infectious diseases research. As you explore the benefits we offer, you will see how BEI Resources can serve as a catalyst for your research efforts worldwide. BEI Resources materials are provided at no cost to registered researchers (additional shipping charges may apply).
We'll take care of the details - so you can focus on your research.
In May 2020, the Centers for Disease Control and Prevention (CDC) issued interim biosafety guidelines recommending that specimens related to COVID-19 be handled in Biosafety Level 3 (BL3) facilities due to the unknowns surrounding SARS-CoV-2. Shortly after, the National Institutes of Health (NIH) Office of Science Policy aligned with this guidance, stating that SARS-CoV-2 best fits the definition of a Risk Group (RG) 3 agent
Monkeypox virus (MPXV), scientifically classified as Orthopoxvirus monkeypox, is a double-stranded enveloped DNA virus and member of the Orthopoxvirus genus of the Poxviridae family.
Simian-human immunodeficiency virus (SHIV) infection in rhesus macaques (RMs) resembles human immunodeficiency virus type 1 (HIV-1) infection in humans and serves as a tool to evaluate candidate AIDS vaccines. HIV-1 clade A, which is associated with a high heterosexual transmission rate compared to other clades, represents the majority of circulating strains in Kenya.
Coxiella burnetii is a highly resilient, gram-negative, obligate intracellular bacterium that causes Q fever, a zoonotic disease with both acute and chronic manifestations. Due to its high infectivity, environmental persistence, and potential use in bioterrorism, C. burnetii is classified as a select agent under U.S. Department of Health and Human Services (HHS) regulations (42 CFR Part 73).
Anopheles gambiae mosquitoes are the primary vectors for the transmission of Plasmodium falciparum, the causative agent of the most severe and debilitating form of human malaria. Gravid female mosquitoes seek hosts for blood meals and need to locate egg-laying (oviposition) sites.
Vector-borne microbial pathogens have evolved a series of strategies to evade the immune system and establish infections in the mammalian host. In this setting, BEI Resources functions as a centralized bioresource for accessibility of reference strains of arthropod vectors to the global public health scientific community. The BEI Vector Resources program currently provides over 60 colonies of live mosquitoes as well as Ixodid and soft ticks, sandflies, black flies and triatomines.
The NIAID Data Ecosystem Discovery Portal (https://data.niaid.nih.gov/) allows researchers to search simultaneously across millions of publicly available datasets to find infectious and immune-mediated disease data for reanalysis and accelerates the work of researchers, leading to faster development of diagnostics, therapeutics, and vaccines.
The Discovery Portal can be used to:
Now available Mpox virus, isolate hMPXV/USA/MA001/2022 (NR-58622), from the current outbreak. For a complete listing of available of Mpox reagents and other Orthopox virus related reagents, click here.
BEI Resources is continually building a comprehensive repository of microbiological and emerging disease related organisms and reagents. Suggestions for materials to be added to our repository are always welcome. Click here to tell us what you don't see in our catalog!
BEI Resources acquires, authenticates, produces and distributes a variety of materials within several biosafety levels and classifications. We understand that some researchers may only choose to order non-infectious research grade reagents through BEI Resources.
The Knowledge Base is an informational database assembled by our Support Specialists and Scientific Staff which provides additional knowledge about the BEI Resources program and reagents through questions and answers.
Sign up to receive catalog information, updates, and other technical information from BEI. BEI takes the privacy of your information very seriously.
If you have Comments, Questions and Suggestions regarding BEI Resources please contact us.